0
13
Journal Articles about Antipsychotics Showing 41-60 of 931
Article | September 01, 2007
Adjunctive Treatment With a Dopamine Partial Agonist, Aripiprazole, for Antipsychotic-Induced Hyperprolactinemia: A Placebo-Controlled Trial
Joo-Cheol Shim, M.D., Ph.D.; Jae-Goo K. Shin, M.D., Ph.D.; Deanna L. Kelly, Pharm.D.; Do-Un Jung, M.D.; Young-Soo Seo, M.D., Ph.D.; Kwang-Hyeon Liu, Ph.D.; Ji-Hong Shon, M.D., Ph.D.; Robert R. Conley, M.D.
The American Journal of Psychiatry. 2007 September ; 9(164):1404-1410
PDFPDF
Article | September 01, 2007
Differential Effects of Aripiprazole on D2, 5-HT2, and 5-HT1A Receptor Occupancy in Patients With Schizophrenia: A Triple Tracer PET Study
David Mamo, M.D., M.Sc.; Ariel Graff, M.D., Ph.D.; Romina Mizrahi, M.D., Ph.D.; C. M. Shammi, M.D.; Françoise Romeyer, Ph.D.; Shitij Kapur, M.D., Ph.D.
The American Journal of Psychiatry. 2007 September ; 9(164):1411-1417
PDFPDF
Article | August 01, 2007
Atypical Antipsychotic Administration During Late Pregnancy: Placental Passage and Obstetrical Outcomes
D. Jeffrey Newport, M.D.; Martha R. Calamaras, B.S.; C. Lindsay DeVane, Pharm.D.; Jennifer Donovan, Ph.D.; Aquila J. Beach, B.S.; Stephanie Winn, M.D.; Bettina T. Knight, B.S.N., R.N.; Bryan B. Gibson, B.S.; Adele C. Viguera, M.D.; Michael J. Owens, Ph.D.; Charles B. Nemeroff, M.D., Ph.D.; Zachary N. Stowe, M.D.
The American Journal of Psychiatry. 2007 August ; 8(164):1214-1220
PDFPDF
Article | July 01, 2007
Efficacy and Tolerability of Olanzapine, Quetiapine, and Risperidone in the Treatment of Early Psychosis: A Randomized, Double-Blind 52-Week Comparison
Joseph P. McEvoy, M.D.; Jeffrey A. Lieberman, M.D.; Diana O. Perkins, M.D., M.P.H.; Robert M. Hamer, Ph.D.; Hongbin Gu, Ph.D.; Arthur Lazarus, M.D., M.B.A.; Dennis Sweitzer, Ph.D.; Christina Olexy; Peter Weiden, M.D.; Stephen D. Strakowski, M.D.
The American Journal of Psychiatry. 2007 July ; 7(164):1050-1060
PDFPDF
Article | July 01, 2007
Effects of Olanzapine, Quetiapine, and Risperidone on Neurocognitive Function in Early Psychosis: A Randomized, Double-Blind 52-Week Comparison
Richard S.E. Keefe, Ph.D.; John A. Sweeney, Ph.D.; Hongbin Gu, Ph.D.; Robert M. Hamer, Ph.D.; Diana O. Perkins, M.D.; Joseph P. McEvoy, M.D.; Jeffrey A. Lieberman, M.D.
The American Journal of Psychiatry. 2007 July ; 7(164):1061-1071
PDFPDF  |    Data Supplements
Treatment in Psychiatry | June 01, 2007
Neuroleptic Malignant Syndrome
Jeffrey R. Strawn, M.D.; Paul E. Keck, Jr., M.D.; Stanley N. Caroff, M.D.
The American Journal of Psychiatry. 2007 June ; 6(164):870-876
PDFPDF  |  CME Activity (3)
Special Article | April 01, 2007
Furor Therapeuticus: Benjamin Rush and the Philadelphia Yellow Fever Epidemic of 1793
Leon Eisenberg, M.D.
The American Journal of Psychiatry. 2007 April ; 4(164):552-555
PDFPDF
Article | April 01, 2007
Adverse Subjective Experience With Antipsychotics and Its Relationship to Striatal and Extrastriatal D2 Receptors: a PET Study in Schizophrenia
Romina Mizrahi, M.D.; Pablo Rusjan, Ph.D.; Ofer Agid, M.D.; Ariel Graff, M.D., Ph.D.; David C. Mamo, M.D., F.R.C.P.(C).; Robert B. Zipursky, M.D., F.R.C.P.(C).; Shitij Kapur, M.D., Ph.D., F.R.C.P.(C).
The American Journal of Psychiatry. 2007 April ; 4(164):630-637
PDFPDF
Article | March 01, 2007
Effectiveness of Olanzapine, Quetiapine, and Risperidone in Patients With Chronic Schizophrenia After Discontinuing Perphenazine: A CATIE Study
T. Scott Stroup, M.D., M.P.H.; Jeffrey A. Lieberman, M.D.; Joseph P. McEvoy, M.D.; Marvin S. Swartz, M.D.; Sonia M. Davis, Dr.P.H.; George A. Capuano, Ph.D.; Robert A. Rosenheck, M.D.; Richard S.E. Keefe, Ph.D.; Alexander L. Miller, M.D.; Irving Belz, M.D.; John K. Hsiao, M.D.; for the CATIE Investigators
The American Journal of Psychiatry. 2007 March ; 3(164):415-427
PDFPDF
Article | March 01, 2007
Effects of Antipsychotic Medications on Psychosocial Functioning in Patients With Chronic Schizophrenia: Findings From the NIMH CATIE Study
Marvin S. Swartz, M.D.; Diana O. Perkins, M.D., M.P.H.; T. Scott Stroup, M.D., M.P.H.; Sonia M. Davis, Dr.P.H.; George Capuano, Ph.D.; Robert A. Rosenheck, M.D.; Fred Reimherr, M.D.; Mark F. McGee, M.D.; Richard S.E. Keefe, Ph.D.; Joseph P. McEvoy, M.D.; John K. Hsiao, M.D.; Jeffrey A. Lieberman, M.D.; for the CATIE Investigators
The American Journal of Psychiatry. 2007 March ; 3(164):428-436
PDFPDF  |  CME Activity (3)  |    Data Supplements
Brief Report | January 01, 2007
A Comparison of Aripiprazole, Methylphenidate, and Placebo for Amphetamine Dependence
Jari Tiihonen, M.D., Ph.D.; Kimmo Kuoppasalmi, M.D., Ph.D.; Jaana Föhr, M.D.; Pekka Tuomola, M.D.; Outi Kuikanmäki, M.D.; Helena Vorma, M.D., Ph.D.; Petteri Sokero, M.D., Ph.D.; Jari Haukka, Ph.D.; Esa Meririnne, M.D.
The American Journal of Psychiatry. 2007 January ; 1(164):160-162
PDFPDF  |    Data Supplements
Reviews and Overviews | December 01, 2006
Clinical Trial-Based Cost-Effectiveness Analyses of Antipsychotic Use
Daniel Polsky, Ph.D.; Jalpa A. Doshi, Ph.D.; Mark S. Bauer, M.D.; Henry A. Glick, Ph.D.
The American Journal of Psychiatry. 2006 December ; 12(163):2047-2056
PDFPDF
Article | December 01, 2006
A Randomized, Double-Blind, Placebo-Controlled Trial of Metformin Treatment of Weight Gain Associated With Initiation of Atypical Antipsychotic Therapy in Children and Adolescents
David J. Klein, M.D., Ph.D.; Elizabeth M. Cottingham, M.D.; Michael Sorter, M.D.; Bruce A. Barton, Ph.D.; John A. Morrison, Ph.D.
The American Journal of Psychiatry. 2006 December ; 12(163):2072-2079
PDFPDF
Article | December 01, 2006
Cost-Effectiveness of Second-Generation Antipsychotics and Perphenazine in a Randomized Trial of Treatment for Chronic Schizophrenia
Robert A. Rosenheck, M.D.; Douglas L. Leslie, Ph.D.; Jody Sindelar, Ph.D.; Edward A. Miller, Ph.D.; Haiqun Lin, Ph.D.; T. Scott Stroup, M.D., M.P.H.; Joseph McEvoy, M.D.; Sonia M. Davis, Dr.P.H.; Richard S.E. Keefe, Ph.D.; Marvin Swartz, M.D.; Diana O. Perkins, M.D., M.P.H.; John K. Hsiao, M.D.; Jeffrey Lieberman, M.D., for the CATIE Study Investigators
The American Journal of Psychiatry. 2006 December ; 12(163):2080-2089
PDFPDF  |    Data Supplements
Article | December 01, 2006
Effectiveness of Switching Antipsychotic Medications
Susan M. Essock, Ph.D.; Nancy H. Covell, Ph.D.; Sonia M. Davis, Dr.P.H.; T. Scott Stroup, M.D.; Robert A. Rosenheck, M.D.; Jeffrey A. Lieberman, M.D.
The American Journal of Psychiatry. 2006 December ; 12(163):2090-2095
PDFPDF  |    Data Supplements
Article | December 01, 2006
Randomized Comparison of Olanzapine Versus Risperidone for the Treatment of First-Episode Schizophrenia: 4-Month Outcomes
Delbert G. Robinson, M.D.; Margaret G. Woerner, Ph.D.; Barbara Napolitano, M.A.; Raman C. Patel, M.D.; Serge M. Sevy, M.D., M.B.A.; Handan Gunduz-Bruce, M.D.; Jose M. Soto-Perello, M.D.; Alan Mendelowitz, M.D.; Ali Khadivi, Ph.D.; Rachel Miller, L.C.S.W.; Joanne McCormack, L.C.S.W.; Beth S. Lorell, L.C.S.W.; Martin L. Lesser, Ph.D.; Nina R. Schooler, Ph.D.; John M. Kane, M.D.
The American Journal of Psychiatry. 2006 December ; 12(163):2096-2102
PDFPDF  |  CME Activity (3)  |    Data Supplements
Article | November 01, 2006
Improvement in Social Competence With Short-Term Atypical Antipsychotic Treatment: A Randomized, Double-Blind Comparison of Quetiapine Versus Risperidone for Social Competence, Social Cognition, and Neuropsychological Functioning
Philip D. Harvey, Ph.D.; Thomas L. Patterson, Ph.D.; Larry S. Potter, M.S.; Kate Zhong, M.D.; Martin Brecher, M.D.
The American Journal of Psychiatry. 2006 November ; 11(163):1918-1925
PDFPDF
Brief Report | November 01, 2006
Reduced Thalamic Volume in Patients With Chronic Schizophrenia After Switching From Typical Antipsychotic Medications to Olanzapine
Babak Khorram, B.Sc.; Donna J. Lang, Ph.D.; Lili C. Kopala, M.D., F.R.C.P.C.; Robert A. Vandorpe, M.D.; Qing Rui, M.B.; Vina M. Goghari, B.A.; Geoffrey N. Smith, Ph.D.; William G. Honer, M.D., F.R.C.P.C.
The American Journal of Psychiatry. 2006 November ; 11(163):2005-2007
PDFPDF
Treatment in Psychiatry | October 01, 2006
Medication-Induced Weight Gain and Dyslipidemia in Patients With Schizophrenia
Wayne S. Fenton, M.D.; Mark R. Chavez, Ph.D.
The American Journal of Psychiatry. 2006 October ; 10(163):1697-1704
PDFPDF  |  CME Activity (3)
Article | October 01, 2006
Hyperlipidemia Following Treatment With Antipsychotic Medications
Mark Olfson, M.D., M.P.H.; Steven C. Marcus, Ph.D.; Patricia Corey-Lisle, Ph.D., R.N.; A.V. Tuomari, M.S.; Patricia Hines, A.S.; Gilbert J. L’Italien, Ph.D.
The American Journal of Psychiatry. 2006 October ; 10(163):1821-1825
PDFPDF
Copyright ©
American
Psychiatric
Association